-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Integra Lifesciences, Raises Price Target to $19

Benzinga·07/16/2026 16:10:03
Listen to the news
Truist Securities analyst Ravi Misra maintains Integra Lifesciences (NASDAQ:IART) with a Hold and raises the price target from $14 to $19.